Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91K Hold
46
0.14% 101
2026
Q1
$5.31K Sell
46
-13
-22% -$1.5K 0.18% 107
2025
Q4
$6.21K Buy
59
+13
+28% +$1.22K 0.18% 103
2025
Q3
$3.89K Sell
46
-1
-2% -$82 0.14% 109
2025
Q2
$3.72K Sell
47
-5
-10% -$397 0.18% 83
2025
Q1
$4.68K Hold
52
0.27% 72
2024
Q4
$5.17K Sell
52
-9
-15% -$928 0.22% 69
2024
Q3
$6.93K Buy
61
+14
+30% +$1.66K 0.62% 27
2024
Q2
$5.82K Sell
47
-2
-4% -$258 0.49% 49
2024
Q1
$6.47K Buy
49
+18
+58% +$2.22K 0.32% 65
2023
Q4
$3.42K Sell
31
-71
-70% -$7.37K 0.17% 140
2023
Q3
$10.5K Buy
102
+20
+24% +$2.16K 0.48% 47
2023
Q2
$9.46K Sell
82
-23
-22% -$2.61K 0.58% 26
2023
Q1
$11.2K Sell
105
-55
-34% -$5.94K 0.75% 22
2022
Q4
$17.8K Buy
+160
New +$16.4K 1.19% 12

Other funds holding MRK

PayPay Securities's MRK Position: Q2 2026 in Review

PayPay Securities held its Merck (MRK) position steady in Q2 2026 at 46 shares worth $5.91K. The position accounts for 0.14% of the portfolio, ranked #101.

PayPay Securities first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $17.8K in Q4 2022. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • PayPay Securities held 46 shares of Merck worth $5.91K as of Q2 2026.
  • PayPay Securities left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.14% of PayPay Securities's portfolio in Q2 2026, its #101 holding.
  • PayPay Securities first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's Merck position peaked at $17.8K in Q4 2022.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.